Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women.

Stenbæk DS, Budtz-Jørgensen E, Pinborg A, Jensen PS, Frokjaer VG.

Psychoneuroendocrinology. 2019 Jan;99:251-256. doi: 10.1016/j.psyneuen.2018.10.016. Epub 2018 Oct 26.

PMID:
30390443
2.

Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology.

Stenbæk DS, Toftager M, Hjordt LV, Jensen PS, Holst KK, Bryndorf T, Holland T, Bogstad J, Pinborg A, Hornnes P, Frokjaer VG.

Hum Reprod. 2015 Jan;30(1):103-10. doi: 10.1093/humrep/deu294. Epub 2014 Nov 14.

PMID:
25398970
3.

Sex hormone manipulation slows reaction time and increases labile mood in healthy women.

Stenbæk DS, Fisher PM, Budtz-Jørgensen E, Pinborg A, Hjordt LV, Jensen PS, Knudsen GM, Frokjaer VG.

Psychoneuroendocrinology. 2016 Jun;68:39-46. doi: 10.1016/j.psyneuen.2016.02.023. Epub 2016 Feb 26.

PMID:
26943343
4.

Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study.

Frokjaer VG, Pinborg A, Holst KK, Overgaard A, Henningsson S, Heede M, Larsen EC, Jensen PS, Agn M, Nielsen AP, Stenbæk DS, da Cunha-Bang S, Lehel S, Siebner HR, Mikkelsen JD, Svarer C, Knudsen GM.

Biol Psychiatry. 2015 Oct 15;78(8):534-43. doi: 10.1016/j.biopsych.2015.04.015. Epub 2015 Apr 27.

PMID:
26004162
5.

Sex-Steroid Hormone Manipulation Reduces Brain Response to Reward.

Macoveanu J, Henningsson S, Pinborg A, Jensen P, Knudsen GM, Frokjaer VG, Siebner HR.

Neuropsychopharmacology. 2016 Mar;41(4):1057-65. doi: 10.1038/npp.2015.236. Epub 2015 Aug 6.

6.

Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.

Knorr U, Vinberg M, Mortensen EL, Winkel P, Gluud C, Wetterslev J, Gether U, Kessing LV.

PLoS One. 2012;7(2):e31980. doi: 10.1371/journal.pone.0031980. Epub 2012 Feb 29.

7.

Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study.

Henningsson S, Madsen KH, Pinborg A, Heede M, Knudsen GM, Siebner HR, Frokjaer VG.

Transl Psychiatry. 2015 Dec 1;5:e688. doi: 10.1038/tp.2015.184.

8.

Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.

Frokjaer VG, Vinberg M, Erritzoe D, Baaré W, Holst KK, Mortensen EL, Arfan H, Madsen J, Jernigan TL, Kessing LV, Knudsen GM.

Neuropsychopharmacology. 2010 Apr;35(5):1129-37. doi: 10.1038/npp.2009.218. Epub 2009 Dec 30.

9.

The neural correlates of Neuroticism differ by sex prospectively mediate depressive symptoms among older women.

Sutin AR, Beason-Held LL, Dotson VM, Resnick SM, Costa PT Jr.

J Affect Disord. 2010 Dec;127(1-3):241-7. doi: 10.1016/j.jad.2010.06.004.

11.

Understanding the relationship between suicidality, current depressed mood, personality, and cognitive factors.

Cameron S, Brown VJ, Dritschel B, Power K, Cook M.

Psychol Psychother. 2017 Dec;90(4):530-549. doi: 10.1111/papt.12123. Epub 2017 Mar 11.

PMID:
28296207
12.

Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study.

Mehta D, Rex-Haffner M, Søndergaard HB, Pinborg A, Binder EB, Frokjaer VG.

Br J Psychiatry. 2018 Nov 20:1-9. doi: 10.1192/bjp.2018.234. [Epub ahead of print]

PMID:
30457060
13.

Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR.

Gingnell M, Comasco E, Oreland L, Fredrikson M, Sundström-Poromaa I.

Arch Womens Ment Health. 2010 Oct;13(5):417-23. doi: 10.1007/s00737-010-0164-4. Epub 2010 May 4.

14.

Personality Does not Influence Exercise-Induced Mood Enhancement Among Female Exercisers.

Lane AM, Milton KE, Terry PC.

J Sports Sci Med. 2005 Sep 1;4(3):223-8. eCollection 2005 Sep 1.

15.

Neuroticism Traits Selectively Impact Long Term Illness Course and Cognitive Decline in Late-Life Depression.

Manning KJ, Chan G, Steffens DC.

Am J Geriatr Psychiatry. 2017 Mar;25(3):220-229. doi: 10.1016/j.jagp.2016.10.006. Epub 2016 Oct 13.

16.

Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.

Frokjaer VG, Mortensen EL, Nielsen FA, Haugbol S, Pinborg LH, Adams KH, Svarer C, Hasselbalch SG, Holm S, Paulson OB, Knudsen GM.

Biol Psychiatry. 2008 Mar 15;63(6):569-76. Epub 2007 Sep 19.

PMID:
17884017
17.

Personality change during depression treatment: a placebo-controlled trial.

Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam J, Shelton R, Schalet B.

Arch Gen Psychiatry. 2009 Dec;66(12):1322-30. doi: 10.1001/archgenpsychiatry.2009.166.

18.

Incidence of depressive symptoms in users of the oral contraceptive.

Fleming O, Seager CP.

Br J Psychiatry. 1978 May;132:431-40.

PMID:
656705
19.

Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.

Peciña M, Love T, Stohler CS, Goldman D, Zubieta JK.

Neuropsychopharmacology. 2015 Mar;40(4):957-65. doi: 10.1038/npp.2014.272. Epub 2014 Oct 13.

20.

Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals.

Strong CM, Nowakowska C, Santosa CM, Wang PW, Kraemer HC, Ketter TA.

J Affect Disord. 2007 Jun;100(1-3):41-8. Epub 2006 Nov 28.

PMID:
17126408

Supplemental Content

Support Center